NTRK1 and pancreatic neoplasm: It is noteworthy that others have found a dramatic increase in the activity of MMP-9 in gemcitabine-resistant pancreatic cancer cells [53], which fits well within our molecular signaling platform of Neu1-MMP-9 cross-talk in regulating ligand-induced receptor tyrosine kinases.